Over 20 Total Lots Up For Auction at One Location - TX Cleansweep 06/25

GE HealthCare launches new era of AI-enhanced, personalized oncology solutions at ESTRO 2024

Press releases may be edited for formatting or style | May 01, 2024 Rad Oncology
CHICAGO — May 1, 2024 — GE HealthCare (Nasdaq: GEHC) today announced Revolution RT,[i] a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients. The new Revolution RT is being unveiled at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2024 Congress in Glasgow, along with an updated and artificial intelligence (AI)-enhanced version of the Intelligent Radiation Therapy (iRT) platform, which interfaces with the Spectronic magnetic resonance imaging (MRI) Planner. Additionally, the company will showcase the newly acquired MIM Software portfolio, as well as other key innovations from GE HealthCare.

One of the biggest challenges of oncology care is the complexity of the disease - both in the many varieties of cancer, and the disparate ways it can present in each individual patient[ii] - requiring diligence and personalization in diagnosis and treatment. Additionally, treatment often requires the expertise of multiple disciplines and experts related to specific organs and systems in the body, resulting in potential delays to diagnosis and timely treatment. According to research published by the British Medical Journal (BMJ), the mortality risk increases 6-13% for every month a diagnosis is delayed[iii], therefore, it is critical to streamline the complex oncology care pathway and reduce the time from diagnosis to treatment, ultimately leading to improved patient outcomes.

“At GE HealthCare, we are committed to advancing the frontiers of oncology treatment through AI-driven technologies that transform and optimize the care continuum,” said Dr. Taha Kass-Hout, chief technology and science officer of GE HealthCare. “Our showcase at ESTRO this year highlights innovations that will allow clinicians to view the patient’s anatomy with great accuracy, helping facilitate precise tumor targeting while aiming to protect nearby healthy tissue. By integrating these capabilities into our systems, we create a precise, more connected, and efficient care environment that accelerates the delivery of personalized care, with the goal of enabling better patient outcomes. This comprehensive approach empowers clinicians around the globe to tackle the most challenging disease states with precision and efficiency.”

You Must Be Logged In To Post A Comment